FDA
-
-
-
-
-
-
-
Selagine Enters into a Collaborative Agreement with Grifols for Development and Commercialization of Immunoglobulin Eye Drops for Treating Dry Eye Disease
-
-
-
-
-
-
-
Grifols' (GRFS) anti-SARS-CoV-2 hyperimmune globulin begins clinical trial in patients with COVID-19
-
-
-
-
-
-
-
People Who Have Recovered from COVID-19 Can Now Donate their Convalescent Plasma in select Grifols U.S. Plasma Donor Centers
-
-
-
-
-
-
-
Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System
-
-
-
-
-
-
-
Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
-
-
-
-
-
323,752 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

